About
A neutral answer, because we have nothing to sell
Peptlas is an information product about public regulatory processes — the same category as a court-docket tracker or a bill-status site. It happens to cover a set of compounds under FDA process.
What it is
A per-compound, source-linked status tracker plus a change-alert email list. It watches official government rulemaking, records what each decision actually means in plain language, and links every entry to its primary source. Clarity is the product; the list of people who want to know the moment a status changes is the asset.
What it isn't
- Not a vendor, marketplace, or affiliate — it sells nothing and links to no store.
- Not a dosing, protocol, or "how to use" tool.
- Not a source of medical or legal advice, and not a maker of any health claim.
That neutrality isn't a disclaimer bolted on afterwards — it's the entire basis of the site's credibility. Because it has no stake in what any status turns out to be, it can just report the status.
Who runs it
Peptlas is maintained by the Peptlas Research Team — a small independent group. We publish under a team name rather than personal names, and we keep the identity pseudonymous on purpose: the credibility should rest on the sources we link and the dates we stamp, not on who we are. The full change history is kept in version control precisely so the record can be audited independently of us.
How to reach us — especially to correct us
If a status here is out of date or wrong, that is the single most valuable thing you can tell us. Email research@peptlas.com with a link to the primary source and we'll verify and update — corrections are logged in thechangelog like any other change.
Our promises
- Independent — no vendor, no sponsor, no affiliate.
- Source-linked — every entry cites its primary source.
- Human-verified — a person approves every published change.
- Current — updated within 24 hours of any official change we detect.
Curious how the tracking actually works? Read the methodology.